| Literature DB >> 10880291 |
K Krakow1, G Polizzi, P Riordan-Eva, G Holder, W N MacLeod, D R Fish.
Abstract
Epilepsy patients treated with vigabatrin may develop symptomatic or asymptomatic concentric visual field constriction due to GABA-associated retinal dysfunction. The prevalence and course of this side effect are not established yet; in previously reported adult patients the visual disturbances seem to be irreversible. We present two patients with a significant improvement of visual field constriction and retinal function after the discontinuation of vigabatrin. These findings suggest that vigabatrin-associated retinal changes are at least partly reversible in some patients, and that these patients may benefit significantly from a withdrawal of vigabatrin. Larger scale clinical studies are needed to identify predictive factors both for the occurrence and reversibility of vigabatrin-associated visual field defects. Copyright 2000 BEA Trading Ltd.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10880291 DOI: 10.1053/seiz.2000.0397
Source DB: PubMed Journal: Seizure ISSN: 1059-1311 Impact factor: 3.184